Purchase Order 75N93025P01027

Award Date 5/27/25
Potential Completion Date 7/31/25
Potential Value $128K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Herndon, VA 20191, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
2
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, awarded a firm fixed price purchase order worth $35,916.00 to 10X Genomics, Inc., a small business manufacturer of life sciences products and services. The award, which was set aside for small businesses, is for the supply of 10X Genomics' Visium HD, Mouse Transcriptome, 6.5 mm product under a brand name restriction. This procurement was conducted using...
This is a $76,217.75 firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Government Scientific Source Inc., a small business provider of laboratory products and equipment. The contract is for the delivery of various 10X Genomics reagent kits used for single-cell analysis and spatial gene expression, including the Chromium Connect and CytAssist product lines. This requirement was...
The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the U.S. Department of Health and Human Services, awarded a $75,963.60 firm fixed price purchase order to 10X Genomics, Inc., a small business manufacturer of life sciences products and services. The award is for the provision of "CHROMIUM KITS AND ACCESSORIES" used to support the agency's biomedical research efforts. 10X Genomics, which holds an indefinite delivery contract with the National...
This firm fixed-price purchase order was awarded to 10X Genomics, Inc., a small business manufacturer of life sciences products and services, by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services. The $59,210 contract is for the delivery of 10X Genomics reagent kits, including the Chromium Next GEM Single Cell 5' HT Kit v2 and the Dual Index Kit TT Set A, to support...
The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), has awarded a $83,135.00 firm fixed price purchase order contract to 10X Genomics, Inc. for 10X Chromium Controller, Next Gen Single Cell Reagents. This contract is set aside for small businesses. The award is for the supply of 10X Genomics' Chromium Single Cell 5' Reagent Kits, Library Construction and Barcoding Kits, B Cell and T Cell VDJ (BCR & TCR) Enrichment Kits, and...
This contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), an institute within the U.S. Department of Health and Human Services, to 10X Genomics, Inc., a small business that provides life sciences technology products and services. The contract, valued at $83,220.00, is for the delivery of 10X Genomics' single cell kits and library constructs. This is a firm fixed-price purchase order contract with a period of performance ending on September 30, 2020. The...
This is a firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to 10X Genomics, Inc., a small business manufacturer of life sciences products and services. The $14,577.00 contract is for the delivery of Chromium Next GEM kits and reagents to support NIAID's biomedical research and development activities. This award is part of a larger indefinite delivery contract between...
This is a $24,992.79 firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the National Institutes of Health (NIH), to 10X Genomics, Inc., a for-profit manufacturer of genomic analysis products. The contract is for the delivery of 10X Expression Kits, which support single-cell RNA sequencing, single-cell ATAC sequencing, multi-omics analysis, and spatial transcriptomics research. This contract is not set aside and...
The Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) awarded a $178,891.74 firm fixed price purchase order to 10X Genomics, Inc. to provide Visium CytAssist Instruments and Visium Spatial Reagents. This contract is a small business set-aside and has a completion date of September 29, 2023. The products and services are to support biomedical research efforts, including optimization slides, reagent kits,...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $43,826.20 firm-fixed-price purchase order to 10X Genomics, Inc. for single-cell reagents and kits. The contract has a period of performance from July 5, 2023 through September 29, 2023, with place of performance in Pleasanton, California. This award was made under a total small business set-aside to fulfill a requirement for Chromium Next GEM Single Cell...

The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency of the U.S. government, awarded a firm fixed-price purchase order to Government Scientific Source Inc., a for-profit organization, for the procurement of 10X Genomics Visium HD and Dual Index reagents. The $128,251.03 contract is to support ongoing NIAID research related to tick-borne diseases that began before January 20, 2025. The contract is not set aside for small businesses. The reagents are critical for processing time-sensitive samples and continuing research directly related to biosafety, human safety, and biosecurity in tick-borne disease studies. This procurement was issued through a simplified acquisition process under FAR Part 13.

Generated 5/24/25, 10:45 AM